- Home
- BEAM vs TALO Comparison
BEAM vs TALO Comparison
Compare BEAM & TALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BEAM | TALO |
|---|---|---|
| Founded | 2017 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7B | 2.3B |
| IPO Year | 2019 | 2017 |
Fundamental Metrics
Financial Performance| Metric | BEAM | TALO |
|---|---|---|
| Price | $27.72 | $14.84 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 5 |
| Target Price | ★ $50.75 | $18.00 |
| AVG Volume (30 Days) | 2.0M | ★ 2.4M |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 82.31 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $24,000.00 | ★ $1,780,070,000.00 |
| Revenue This Year | N/A | $4.18 |
| Revenue Next Year | $33.77 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 33.33 | N/A |
| 52 Week Low | $15.52 | $6.76 |
| 52 Week High | $36.44 | $17.01 |
Technical Indicators
Market Signals| Indicator | BEAM | TALO |
|---|---|---|
| Relative Strength Index (RSI) | 48.95 | 51.55 |
| Support Level | $25.89 | $10.49 |
| Resistance Level | $29.06 | $17.01 |
| Average True Range (ATR) | 1.67 | 0.65 |
| MACD | 0.18 | -0.07 |
| Stochastic Oscillator | 47.35 | 58.96 |
Price Performance
Historical ComparisonAbout BEAM Beam Therapeutics Inc.
Beam Therapeutics Inc is a biotechnology company committed to creating a new class of precision genetic medicines based on its proprietary base editing technology, with a vision of providing lifelong cures to patients suffering from serious diseases. The company is focused on its programs in the hematology and genetic disease portfolios, which comprise different product candidates in its pipeline, such as BEAM-101, which is being developed to target Sickle Cell Disease, BEAM-302, a liver-targeting lipid nanoparticle, being developed to target Alpha-1 antitrypsin deficiency, and other drug candidates including BEAM-302, BEAM-103 & 104. The company views its operations and manages its business in one operating segment, operating exclusively in the United States.
About TALO Talos Energy Inc.
Talos Energy Inc is an independent oil and gas company predominantly involved in offshore exploration and production. The company has operations in the United States, the Gulf of Mexico, and offshore Mexico. The company's operating segments are; exploration and production of oil, natural gas and NGLs, and the CCS segment. Its revenue is generated from the sale of oil, natural gas, and NGL quantities sold to purchasers.